Over 20 million people in the United States suffer from treatment-resistant chronic pain, and over 6 million from treatment-resistant depression.
SPIRE has developed a noninvasive medical device to treat the deep brain neural circuits involved in these disorders without drugs or surgeries. The device emits low-intensity ultrasonic waves into the malfuctioning deep brain regions, thus providing an effective reset.
The technology is currently evaluated for the following indications:
Chronic Widespread Pain
Major Depression
PTSD